Skip to content

Tectochrysin Alleviates Idiopathic Pulmonary Fibrosis via Inhibiting PI3K/AKT/mTOR Signaling Pathway by Targeting PI3K p85.

Oct 2026 · Pulmonary Pharmacology & Therapeutics · pp. 102455 · 0 citations · 32 references
Medicine

Abstract

Objective

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by progressive dyspnea, with high morbidity and mortality globally. Tectochrysin, a flavonoid with several pharmacological activities, has not yet been explored for its anti-fibrotic effects. This study aims to investigate the role of tectochrysin in bleomycin (BLM)-induced IPF in mice, as well as its mechanism and target.

Methods

Intratracheal injection of BLM was employed to induce IPF in mice, and the protective effect of tectochrysin was evaluated through multiple experimental techniques. In vitro, TGF-β1-stimulated human embryonic lung fibroblasts (HELFs) was used to assess the anti-fibrotic activity of tectochrysin. Network pharmacology, bioinformatics, molecular docking, cellular thermal shift assay and drug affinity responsive target stability experiments were employed to explore the anti-fibrotic targets and mechanisms.

Results

In vivo, tectochrysin effectively mitigated BLM-induced extracellular matrix deposition, reduced the expression of fibrosis-related factors, and ameliorated lung injury. In vitro, tectochrysin dose-dependently inhibited TGF-β-induced α-SMA and collagen 1 expression, as well as the migration of HELFs. Notably, the inhibitory effect of tectochrysin on HELF activation and migration reached a level comparable to that of the positive control, pirfenidone, in this in vitro system. Further investigations revealed that tectochrysin directly bind to PI3K p85, forming hydrogen bonds with THR-369 and LYS-382 residues, thereby inhibiting the activation of the PI3K/AKT/mTOR signaling pathway.

Conclusion

Tectochrysin can alleviate BLM-induced IPF by targeting PI3K p85, thereby inhibiting the activation of the PI3K/AKT/mTOR signaling pathway. This study uncovers a previously unreported anti-fibrotic activity of tectochrysin, and highlight its potential as a candidate for the treatment of IPF.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.